Insmed | 销售毛利



Gross Profit On Sales 更改 日
BioMarin Pharmaceutical USD 593.59M 17.59M 2025-03
Cytokinetics -160545000 81.19M 2024-09
DBV Technologies -30442000 30.56M 2024-09
Dynavax Technologies USD 54.4M 4.23M 2025-03
Gilead Sciences USD 5.99B 17M 2024-12
Insmed USD 71.54M 6.75M 2025-03
Novartis USD 10.24B 313M 2024-12
Regeneron Pharmaceuticals USD 2.56B 659.4M 2025-03
Sarepta Therapeutics USD 607.29M 81.18M 2025-03
Ultragenyx Pharmaceutical USD 110.63M 37.35M 2025-03
Vertex Pharmaceuticals USD 2.49B 109.3M 2024-12



Insmed 销售毛利 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2025.